tiprankstipranks

Nir Naor Insider Profile

4 Followers
Nir Naor, Director at Brainstorm Cell Therapeutics, holds 300.00K shares in AxoGen (Ticker: AXGN), holds 12.00K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).
tipranks
Nir Naor

Nir Naor
Brainstorm Cell Therapeutics (BCLI)
Director

Not Ranked
Nir Naor has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
99.68%
0.32%
A breakdown of Nir Naor's holdings

Insider Roles

AxoGen
(AXGN)
CFO
Brainstorm Cell Therapeutics
(BCLI)
Director
Roles that Nir Naor holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Nir Naor

Nir Naor's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Brainstorm Cell Therapeutics
Jun 21, 2023
Director
Uninformative Buy
$6.41K
AxoGen
Jan 04, 2024
CFO
Uninformative Buy
$1.99M
List of latest transactions for each holding click on a transaction to see Nir Naor's performance on stock

Nir Naor insider profile FAQ

What is the percentage of profitable transactions made by Nir Naor?
The percentage of profitable transactions made by Nir Naor is ―.
    What is the average return per transaction made by Nir Naor?
    The average return per transaction made by Nir Naor is ―.
      What stocks does Nir Naor hold?
      Nir Naor holds: BCLI, AXGN stocks.
        What was Nir Naor’s latest transaction?
        Nir Naor latest transaction was an Uninformative Buy of ―.
          What was Nir Naor's most profitable transaction?
          Nir Naor’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Nir Naor's role in Brainstorm Cell Therapeutics?
            Nir Naor's role in Brainstorm Cell Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.